Lichen sclerosus is a chronic inflammatory skin condition that most often affects the genital and anal area, causing white, thinned patches of skin along with itching, pain, and, when left untreated, permanent scarring. Postmenopausal women are the group most commonly diagnosed, though men, children, and adolescents develop it too.1PubMed Central. Lichen sclerosus: The 2023 update Despite being well-described in the medical literature for over a century, it remains widely underdiagnosed, frequently confused with yeast infections or other vulvar conditions, and poorly understood by many of the clinicians patients first see about it.
What Causes It
The honest answer is that nobody knows the full cause, but the evidence points strongly toward an autoimmune process. Roughly three-quarters of people with lichen sclerosus carry autoantibodies against a protein called extracellular matrix protein 1 (ECM1), which helps maintain the structure of skin. In one study, antibodies to ECM1 were found in about 74% of lichen sclerosus patients compared with only 7% of controls.2PubMed. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus Further analysis showed these autoantibodies target specific regions of the ECM1 protein and belong predominantly to one particular subclass of IgG.3PubMed. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus This doesn’t mean the antibodies alone cause the disease, but it does suggest the immune system is mistakenly attacking normal skin components.
Genetics also play a role. A large genome-wide meta-analysis identified 14 genomic risk loci for lichen sclerosus, with one of the strongest signals coming from a specific immune-system gene, HLA-DRB1*12:01. Women carrying this variant had roughly 2.5 times the odds of developing the condition, and men showed a similarly elevated risk.4British Journal of Dermatology. Genome-wide meta-analysis in lichen sclerosus identifies 14 genomic risk loci Familial clustering has been reported too, with several HLA markers appearing repeatedly across affected families.5PubMed. HLA markers in familial Lichen sclerosus The genetic picture suggests that lichen sclerosus shares immune-pathway features with other autoimmune diseases, which helps explain why it so often co-occurs with conditions like autoimmune thyroid disease.
Beyond genetics and autoimmunity, oxidative stress has emerged as another piece of the puzzle. Chronic oxidative damage to genital skin appears to feed a cycle of tissue injury, inflammation, and further immune activation.6PubMed Central. Exploring Genital Lichen Sclerosus: Navigating from Pathophysiology to Precise Diagnostic Approaches Local irritation, friction, and hormonal changes have all been proposed as contributing triggers, though none of these have been proven to independently cause the disease.
Symptoms in Women
Vulvar lichen sclerosus typically presents as intense itching, often described as the single most disruptive symptom. Pain, burning, and discomfort during intercourse are also common. The affected skin usually turns white and thin, sometimes described as having a “cigarette paper” or parchment-like quality. Over time, the chronic inflammation can cause the tissue to scar and fuse, reshaping the vulvar anatomy in ways that are sometimes irreversible.7PubMed Central. Vulvar Lichen Sclerosus: A Literature Review with Consideration of Integrative Therapies
In a prospective study of 507 women with vulvar lichen sclerosus, over half already had structural changes to their vulvar anatomy at the time of their first visit. About 16% had anterior fusion, meaning the clitoral hood or inner lips had fused, while about 11% had posterior fusion that narrowed or partially closed the vaginal opening. Nearly a quarter had both.8JAMA Dermatology. Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women This kind of scarring can bury the clitoris, narrow the introitus, and make intercourse painful or impossible. Surgical techniques to address these changes, including release of clitoral phimosis and introital stenosis, have improved in recent years, but prevention through early treatment remains preferable.9PubMed Central. Vulvar Lichen Sclerosus: Current Perspectives
Symptoms in Men
In men, lichen sclerosus (historically called balanitis xerotica obliterans) most often affects the foreskin and the head of the penis. White, hardened plaques develop on the foreskin or glans, and the scarring can tighten the foreskin to the point where it can no longer retract. In more advanced cases, the urethral opening narrows, interfering with urine flow.10PubMed. Penile lichen sclerosus (balanitis xerotica obliterans) In a cohort of men with lichen sclerosus who underwent circumcision, about 22% went on to develop urethral strictures, which sometimes required additional surgical procedures.11PubMed Central. Prevalence and sequelae of penile lichen sclerosus in males presenting for circumcision in regional Australia Male lichen sclerosus is almost certainly underdiagnosed because many men attribute early symptoms to normal aging or minor irritation, and the condition is less widely discussed than the vulvar form.
Why It Gets Misdiagnosed So Often
The average delay from first symptoms to a correct diagnosis is striking. In a study of girls and adolescents at a Swiss center, the average delay was three years, with many patients seeing a wide range of specialists before anyone identified the condition.12PubMed Central. Paediatric and adolescent vulvar lichen sclerosus: delay in diagnosis Adult women face similar delays. A systematic review of barriers to diagnosis in primary care found that both patients and clinicians reported confusion with candidiasis (yeast infections) as a major factor. Lichen planus, vitiligo, and lichen simplex chronicus were also frequently cited as look-alikes that led clinicians down the wrong path.13Clinical and Experimental Dermatology. A systematic review of the barriers to diagnosis of vulval lichen sclerosus in primary care
Compounding the problem, some patients present without the hallmark itch. A case series documented women whose lichen sclerosus was painless and itch-free, which contributed to months or years of incorrect treatment for other conditions.14PubMed Central. Lichen sclerosus: a potpourri of misdiagnosed cases based on atypical clinical presentations Early-stage disease is particularly tricky: the characteristic thickening and whitening haven’t fully developed yet, and under the microscope the inflammatory pattern overlaps with other conditions.15Indian Journal of Dermatology, Venereology and Leprology. Clinical and histopathological spectrum of genital lichen sclerosus in 133 cases: Focus on the diagnosis of pre-sclerotic disease All of this means that if you’ve been told your vulvar or penile symptoms are “just” a yeast infection and treatment keeps failing, lichen sclerosus deserves a place on the list of possibilities.
Treatment With Topical Steroids
The first-line treatment for lichen sclerosus, for both adults and children, is a potent topical corticosteroid. Clobetasol propionate ointment (the strongest class available) is the most widely studied option. A typical induction regimen involves daily application for about three months, with the goal of suppressing the inflammation enough to clear symptoms and begin reversing the white, thickened skin changes.16JAMA Dermatology. Vulvar Lichen Sclerosus: Effect of Long-term Topical Application of a Potent Steroid on the Course of the Disease A randomized trial comparing clobetasol propionate to mometasone furoate (a slightly less potent steroid) found both were similarly effective, with about 89% of patients in each group responding during a 12-week treatment phase.17British Journal of Dermatology. First randomized trial on clobetasol propionate and mometasone furoate in the treatment of vulvar lichen sclerosus: results of efficacy and tolerability
The word “remission” rather than “cure” is used deliberately. Lichen sclerosus can and does come back when treatment stops, which is why long-term maintenance therapy is so important. A randomized study found that applying mometasone furoate ointment just twice a week, after the disease had been brought under control, was effective at preventing relapse over nearly a year of follow-up.18British Journal of Dermatology. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study And in girls diagnosed before puberty, the difference between those who stuck with maintenance therapy and those who didn’t was dramatic: over 93% of adherent patients stayed in complete remission with no scarring, while fewer than 8% of non-adherent patients achieved the same, and nearly 70% of those who stopped treatment saw their disease progress.19PubMed. Prepubertal-Onset Vulvar Lichen Sclerosus: The Importance of Maintenance Therapy in Long-Term Outcomes
People sometimes worry about using a potent steroid on delicate skin for years. This concern is reasonable, but the evidence consistently shows that the tissue damage from untreated lichen sclerosus is far worse than the side effects of properly supervised topical steroid use. Thinning of the skin, the most common fear, is uncommon at the doses and frequencies used for maintenance, and is reversible if it occurs. By contrast, the scarring from uncontrolled disease is not.
When Steroids Don’t Work
A minority of patients respond poorly to topical steroids. For them, calcineurin inhibitors like tacrolimus and pimecrolimus represent the main alternative. These are immune-modulating ointments originally developed for eczema. In small studies, tacrolimus ointment improved symptoms in steroid-resistant patients, though objective skin findings didn’t always improve as much as the patient’s comfort level suggested.20PubMed. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment An advantage of these agents over corticosteroids is that they do not cause skin thinning.21JAMA Dermatology. Successful Treatment of Anogenital Lichen Sclerosus With Topical Tacrolimus Pimecrolimus has also shown promise in small case series.22PubMed. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases Head-to-head trials comparing these drugs to clobetasol are still needed, however, and calcineurin inhibitors remain a second-line choice rather than a replacement for steroids.
Platelet-rich plasma (PRP) injections have generated interest as an emerging therapy. Patients in early studies reported improved quality of life, but objective measures of disease activity haven’t shown clear benefit, and there’s been no standardization of how the PRP is prepared or injected, making it hard to compare results across studies.23PubMed Central. Platelet-rich plasma for the treatment of lichen sclerosus For men with severe foreskin tightening, circumcision is often curative for foreskin disease, though it doesn’t prevent lichen sclerosus from affecting the glans or urethra.
The Cancer Risk
This is the part that worries people most, and the risk is real but often overstated. Lichen sclerosus is a recognized precursor to squamous cell carcinoma of the vulva and penis, but the absolute risk for any individual patient is low. Most estimates suggest that around 4–6% of women with vulvar lichen sclerosus will develop vulvar cancer over their lifetime, and the percentage in men appears to be in a broadly similar range. What’s striking is the relative risk: a Danish study covering 26 years found that men with penile lichen sclerosus had nearly 16 times the rate of penile squamous cell carcinoma compared with the general male population, and the risk increased with longer follow-up and younger age at diagnosis.24PubMed Central. Histologically verified penile lichen sclerosus-Incidence in Denmark over 26 years and long-term risk of penile and non-penile cancer
In a study of 86 uncircumcised men with genital lichen sclerosus, five developed malignant or premalignant changes, with an average lag time from disease onset to cancer of 17 years.25PubMed. Penile cancer among patients with genital lichen sclerosus That long timeline underscores why lifelong monitoring matters. On the vulvar side, researchers have identified potential biomarkers that could eventually help clinicians predict which patients are at higher risk: one study found that abnormal p53 staining in lichen sclerosus tissue was a strong independent predictor of progression to cancer.26PubMed. DNA Methylation and p53 Immunohistochemistry as Prognostic Biomarkers for Vulvar Lichen Sclerosus These biomarkers are not yet part of routine clinical practice, but they may eventually allow a more personalized approach to surveillance.
The reassuring flip side: consistent treatment with topical steroids appears to reduce the cancer risk substantially. Adequate long-term disease control suppresses the chronic inflammation that drives malignant transformation, which is yet another reason that maintenance therapy matters far beyond itch control.
The Impact on Sexual Health
Sexual dysfunction is extremely common and often underappreciated by clinicians who focus only on the skin findings. A meta-analysis estimated that about 59% of people with lichen sclerosus experience sexual dysfunction, with painful intercourse being the most frequently reported problem.27PubMed. Lichen Sclerosus and Sexual Dysfunction: A Systematic Review and Meta-Analysis In a study comparing women with lichen sclerosus to healthy controls, those with the condition reported less frequent sexual activity, were less likely to have vaginal intercourse even when they considered it important, and were far less satisfied with the sexual activity they did have. Nearly a quarter of women with lichen sclerosus said sex was rarely or never satisfactory, compared to zero percent of healthy controls.28PubMed Central. The Impact of Vulvar Lichen Sclerosus on Sexual Dysfunction
A systematic review cataloguing sexual health consequences found that the damage goes beyond physical symptoms. Women reported decreased genital self-image, feelings of inadequacy, and negative effects on their intimate relationships. Standard quality-of-life questionnaires consistently showed sexual functioning as one of the most affected domains.29Sexual Medicine Reviews. A systematic review of sexual health consequences among women with lichen sclerosus These findings suggest that treating lichen sclerosus adequately means addressing sexual health directly, not just managing the skin.
Lichen Sclerosus in Children
Lichen sclerosus is not just an adult disease. Prepubertal girls are the second-most-affected group, and there is a persistent myth that the condition resolves on its own once puberty arrives. The evidence doesn’t support this. A prospective case series followed girls who developed lichen sclerosus before puberty into adolescence and young adulthood. Of 12 who stayed under surveillance, only three achieved sustained remission, all before their first period. The rest continued to need treatment.30PubMed. Childhood onset vulvar lichen sclerosus does not resolve at puberty: a prospective case series
The good news is that children respond well to the same topical steroid regimens used in adults. In a study of 36 premenarchal girls, 83% achieved remission with clobetasol propionate. However, nearly half of those who remitted later relapsed and needed intermittent maintenance therapy for an average of over three years.31PubMed. The course of lichen sclerosus diagnosed prior to puberty The message for parents and pediatricians is clear: treatment works, but the condition should be monitored long-term rather than assumed to have disappeared at puberty.
When Lichen Sclerosus Gets Mistaken for Abuse
One of the most distressing situations that can arise with pediatric lichen sclerosus is misidentification as evidence of child sexual abuse. The bruising, purpura (tiny hemorrhages), and skin splitting that can occur in genital lichen sclerosus can closely mimic findings seen in non-accidental trauma.32PubMed Central. Pediatric Lichen Sclerosus and Non-Accidental Trauma: A Systematic Review of Distinguishing Features and Co-Occurrence Cases of children being referred for suspected sexual abuse when lichen sclerosus was the actual cause have been documented since at least the late 1980s.33JAMA. Dermatologic Conditions Misdiagnosed as Evidence of Child Abuse
This cuts both ways. Clinicians need to include lichen sclerosus in their differential when evaluating genital findings in children, so that families aren’t put through the ordeal of a false abuse investigation. At the same time, having a diagnosis of lichen sclerosus doesn’t rule out abuse; the two can co-occur, and a child with genital skin disease still deserves a careful, complete evaluation. Awareness of lichen sclerosus among pediatricians, emergency physicians, and child-protection teams is essential for getting this balance right.
Autoimmune Overlap With Thyroid Disease
People with lichen sclerosus are more likely to have other autoimmune conditions, and thyroid disease is the most well-documented association. A meta-analysis found that lichen sclerosus patients had roughly 2.4 times the odds of having autoimmune thyroid disease compared to the general population, and about twice the odds of having hyperthyroidism specifically.34PubMed Central. The risk of thyroid diseases in lichen sclerosus patients: a systematic review and meta-analysis Vitiligo, alopecia areata, and pernicious anemia have also been reported at higher rates, though the data on those associations are thinner. The practical takeaway is that if you’re diagnosed with lichen sclerosus and haven’t had your thyroid checked recently, it’s worth asking about.
The Vulvar Microbiome
An emerging area of research involves the microbial communities that live on vulvar skin and how they differ in lichen sclerosus. A study comparing healthy controls to women with lichen sclerosus found significant differences in microbial diversity. Healthy vulvar skin hosted a mixed community of bacteria common to vaginal, anal, and general skin surfaces. In women with lichen sclerosus, certain bacterial groups were less abundant, and there were higher proportions of Papillomaviridae sequences.35PubMed Central. The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions Whether these microbial shifts are a cause or a consequence of the disease is unknown. But the finding that the lichen sclerosus microbiome looks different from healthy skin opens the door to questions about whether restoring microbial balance might one day be part of treatment, similar to ongoing research in gut and skin microbiome therapies for other inflammatory conditions.
Extragenital Lichen Sclerosus
Though the genitals are by far the most common site, lichen sclerosus can appear on other parts of the body. Extragenital disease typically shows up as white, slightly raised or flat patches on the trunk, upper arms, breasts, or thighs. These patches usually don’t itch as intensely as genital lesions, and they don’t carry the same cancer risk. Some people have both genital and extragenital involvement, while a small minority have skin changes only on non-genital sites. Extragenital lichen sclerosus is thought to be relatively uncommon, and there’s limited research on what triggers it to show up in one location versus another.36PubMed Central. Extragenital lichen sclerosus: a comprehensive review of clinical features and treatment Treatment follows the same general approach — topical steroids — but the stakes are lower because scarring in these areas doesn’t carry the same functional consequences as genital scarring.